Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Bromine is a naturally occurring element used in clinical medicine primarily within non-standardized allergenic extracts and historically as a sedative. It belongs to the class of non-standardized food and plant allergenic extracts, playing a role in diagnostic and therapeutic immunology.
Name
Bromine
Raw Name
BROMINE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
43
Variant Count
63
Last Verified
February 17, 2026
About Bromine
Bromine is a naturally occurring element used in clinical medicine primarily within non-standardized allergenic extracts and historically as a sedative. It belongs to the class of non-standardized food and plant allergenic extracts, playing a role in diagnostic and therapeutic immunology.
Detailed information about Bromine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Bromine.
Bromine (Br, atomic number 35) is a halogen element that exists as a deep-red, volatile liquid at room temperature. In the clinical landscape of 2026, Bromine is primarily recognized not as a standalone therapeutic agent in its elemental form, but through its derivatives—bromides—and its inclusion in complex biological products. According to the FDA’s Established Pharmacologic Class (EPC) system, Bromine is categorized under Non-Standardized Food Allergenic Extracts and Non-Standardized Plant Allergenic Extracts. This classification reflects its utility in the field of allergy and immunology, where bromine-containing compounds or bromine-treated extracts are utilized for diagnostic skin testing and, in some instances, allergen immunotherapy (SIT).
Historically, bromine salts (such as potassium bromide) were the first effective medications for epilepsy, introduced in the mid-19th century. While they have largely been superseded by modern anticonvulsants and benzodiazepines, the pharmacological footprint of bromine remains significant in toxicology and specialized diagnostic medicine. In contemporary practice, your healthcare provider may encounter bromine in the context of environmental exposures, specialized chemical allergens, or as a trace component in complex nutritional and hormonal formulations, including those related to l-Thyroxine and Vitamin C preparations where bromine may serve as a stabilizing agent or trace element.
The mechanism of action for bromine depends entirely on its chemical state and the clinical context of its use. When utilized in Allergenic Extracts, bromine functions as a part of a complex biological matrix. In diagnostic testing (such as the skin prick test), the extract is introduced to the patient's skin. If the patient has specific IgE antibodies to the allergen, a type I hypersensitivity reaction occurs, leading to mast cell degranulation and the release of histamine, which produces a measurable wheal-and-flare response. This allows healthcare providers to identify specific sensitivities to food or plant proteins.
At a molecular level, the bromide ion (Br⁻) is a potent central nervous system (CNS) depressant. It works by competing with chloride ions for transport across neuronal membranes. Because bromide ions pass through GABA-A receptor-gated chloride channels more effectively than chloride ions themselves, they hyperpolarize the neuron. This hyperpolarization increases the threshold for action potentials, effectively slowing down neuronal firing and producing sedative and anticonvulsant effects. This mechanism is why bromides were historically used to treat 'nervous disorders' and seizures.
Furthermore, in the context of Acetylcholine Release Inhibitors and Adrenergic Agonists, bromine's presence in certain molecular structures can modulate the affinity of ligands for their respective receptors. In osmotic applications, bromine salts contribute to the tonicity of solutions, facilitating the movement of water across semi-permeable membranes, which is the basis for its classification in some osmotic laxative contexts.
The pharmacokinetics of bromine, particularly as the bromide ion, are unique among medicinal elements due to its extremely long half-life and its relationship with chloride.
Bromine and its derivatives are utilized in several specialized areas of medicine:
Bromine is not typically sold as a standalone 'Bromine' pill. Instead, it is available in the following forms:
> Important: Only your healthcare provider can determine if Bromine or its derivatives are appropriate for your specific diagnostic or therapeutic needs. Never attempt to self-administer elemental bromine, as it is highly corrosive and toxic.
Dosage for bromine-containing compounds varies significantly based on the intended use and the specific formulation prescribed by a healthcare provider.
For diagnostic purposes, such as skin prick testing, the concentration is usually measured in Protein Nitrogen Units (PNU) or weight/volume (w/v) ratios (e.g., 1:10 or 1:20). A single drop (approximately 0.05 mL) is applied to the skin surface, followed by a puncture or scratch. Results are interpreted by a specialist after 15 to 20 minutes.
In the rare instances where bromide salts are used for sedation or seizure control in adults, doses historically ranged from 500 mg to 2 grams daily, often divided into multiple doses. However, due to the risk of accumulation, modern clinicians rarely exceed 1 gram per day, and blood levels must be monitored strictly to maintain a therapeutic range (typically 50 to 150 mg/dL).
Bromine derivatives must be used with extreme caution in children.
Since bromine is primarily excreted by the kidneys, patients with impaired renal function are at a significantly higher risk of toxicity (bromism).
No specific dose adjustments are required for hepatic impairment, as bromine does not undergo liver metabolism. However, patients with liver disease often have fluid balance issues which can affect the distribution volume of bromide ions.
Elderly patients often have declining renal function (even with normal creatinine levels) and are more susceptible to the CNS-depressant effects of bromine. Lower starting doses and slower titration are mandatory. Healthcare providers typically monitor for signs of confusion or lethargy, which can be early indicators of accumulation.
If you miss a dose of a bromine-containing medication, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of toxicity due to bromine's long half-life.
Bromine overdose can be acute or chronic (bromism).
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as sudden changes can affect seizure thresholds or lead to withdrawal-like symptoms.
When bromine is used in therapeutic concentrations or through environmental exposure, several common side effects may emerge. These are often related to the ion's effect on the central nervous system and the skin.
> Warning: Stop taking Bromine-containing products and call your doctor immediately if you experience any of the following:
Prolonged use of bromine leads to its accumulation in nearly all body tissues. Chronic Bromism is the primary concern with long-term use. This syndrome involves a progressive decline in cognitive function, emotional lability (mood swings), and persistent neurological deficits. Because bromine replaces chloride in the body, long-term use can lead to chronic electrolyte imbalances that affect kidney function and bone density. Furthermore, the skin changes associated with bromoderma may become chronic, leading to hyperpigmentation or thickened skin patches.
As of 2026, there are no specific FDA Black Box Warnings for 'Bromine' as an element. However, medications containing bromide derivatives (such as those used for respiratory or GI conditions) carry their own specific warnings. For historical bromide salts, the primary safety concern is the narrow therapeutic index and the high risk of cumulative toxicity. Healthcare providers treat the risk of bromism with the same level of caution as a black box warning, requiring regular blood level monitoring and frequent neurological assessments.
Report any unusual symptoms, especially changes in mood or skin condition, to your healthcare provider immediately.
Bromine is a potent chemical and pharmacological agent that requires careful handling and medical supervision. Patients must be aware that bromine has a very long half-life, meaning it stays in the body for weeks after the last dose is taken. This leads to a significant risk of 'stacking' or accumulation, where the drug builds up to toxic levels even if the daily dose seems small.
Always inform your healthcare provider if you are on a low-salt (low-sodium chloride) diet. Because the body treats bromide and chloride similarly, a lack of salt will cause the kidneys to retain bromine, rapidly leading to toxicity. Conversely, a sudden increase in salt intake can cause bromine levels to drop too quickly, potentially triggering seizures if the drug is being used for epilepsy.
No FDA black box warnings for Bromine are currently issued for its use in allergenic extracts or as a trace element. However, clinicians are advised that the lack of a black box warning does not imply absolute safety, particularly regarding the risk of severe allergic reactions during diagnostic testing.
If you are prescribed bromine-containing medications for systemic use, the following monitoring is typically required:
Bromine frequently causes drowsiness, slowed reflexes, and blurred vision. Do not drive, operate heavy machinery, or engage in dangerous activities until you know how bromine affects you. The sedative effects are often more pronounced in the first few weeks of treatment or after a dose increase.
Alcohol significantly increases the CNS-depressant effects of bromine. Combining the two can lead to dangerous levels of respiratory depression, extreme sedation, and an increased risk of falls or accidents. It is strongly advised to avoid alcohol entirely while taking bromine-containing medications.
Do not stop taking bromine-containing medications suddenly. Abrupt discontinuation can lead to a 'rebound' effect, especially if used for seizure control, potentially resulting in status epilepticus (continuous seizures). A gradual tapering schedule, supervised by a healthcare provider, is necessary to allow the body to re-equilibrate its chloride-bromide balance.
> Important: Discuss all your medical conditions, especially kidney disease and thyroid problems, with your healthcare provider before starting Bromine.
Bromine significantly interferes with standard laboratory tests for Chloride. Most automated lab analyzers cannot distinguish between bromide and chloride ions. Consequently, a patient with high bromine levels will show a 'falsely elevated' chloride level (hyperchloremia) and a 'falsely low' anion gap. If you are taking bromine, you must inform the lab so they can perform a corrected chloride measurement.
For each major interaction, the mechanism usually involves the renal competition between halides or additive pharmacodynamic effects on the GABA-A receptor. Management typically involves dose adjustment and frequent serum monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any changes to your dietary salt intake.
Bromine and its derivatives must NEVER be used in the following circumstances:
In these conditions, the benefits must be carefully weighed against the risks:
Patients who are allergic to other halogens (specifically iodine) may have a higher theoretical risk of reacting to bromine, although cross-reactivity is not always clinically significant. However, patients who react to one bromide-containing drug (e.g., Tiotropium Bromide) should be closely monitored if another bromine-based product is introduced.
> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and mental health status, before prescribing Bromine or performing allergenic testing.
Bromine and bromide ions readily cross the placenta. High levels of bromine in the fetus can lead to 'neonatal bromism,' characterized by poor muscle tone (floppy baby syndrome), lethargy, and a weak cry. There is also a theoretical risk of developmental delays if the fetus is exposed to high levels chronically. Bromine should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It is generally avoided during the first trimester unless absolutely necessary.
Bromide is excreted into breast milk in significant quantities. Nursing infants exposed to bromide via breast milk may develop excessive somnolence (sleepiness) and skin rashes. The American Academy of Pediatrics has historically suggested that bromide should be used with caution by nursing mothers. If bromine use is required, the infant should be closely monitored for lethargy and poor feeding, or formula feeding should be considered.
Bromine is not FDA-approved for general therapeutic use in children. Its use is limited to diagnostic allergenic extracts. Children are more sensitive to the CNS effects of bromine and may develop paradoxical excitement or severe sedation. Long-term effects on brain development in children have not been adequately studied. In diagnostic settings, pediatric patients must be monitored for at least 30 minutes post-procedure for any signs of systemic reaction.
Elderly patients are at the highest risk for bromine-related complications. Age-related declines in renal function mean that bromine clears more slowly. Furthermore, the 'blood-brain barrier' in older adults may be more permeable, leading to higher CNS concentrations. Geriatric patients are particularly prone to 'bromide psychosis' and memory impairment, which can be misdiagnosed as Alzheimer's disease. Fall risk is also significantly increased due to ataxia.
As the primary elimination organ, the kidney's health is paramount. In patients with a GFR of 30-60 mL/min, the half-life of bromine can double or triple. Dialysis (hemodialysis) is highly effective at removing bromine, so patients on dialysis may require 'top-up' doses if the drug is being used therapeutically, though this is a complex clinical scenario requiring specialist oversight.
While the liver does not metabolize bromine, hepatic impairment often co-occurs with hypoalbuminemia or ascites. This changes the volume of distribution for the bromide ion, making the serum concentration unpredictable. No specific dose adjustment is standardized, but clinical monitoring for toxicity is essential.
> Important: Special populations require individualized medical assessment and often more frequent lab monitoring to ensure safety.
Bromine, specifically in the form of the bromide ion (Br⁻), exerts its primary pharmacological effect through the modulation of ligand-gated ion channels. It acts as a GABA-A receptor agonist enhancer. The bromide ion has a smaller hydrated radius than the chloride ion, allowing it to pass more easily through the GABA-activated chloride channels in neurons. When bromide replaces chloride, it causes a more profound hyperpolarization of the postsynaptic membrane. This shifts the resting membrane potential further away from the firing threshold, resulting in a generalized stabilization of the central nervous system. This explains its historic use as both a sedative and an anticonvulsant.
In the context of Allergenic Extracts, bromine's role is structural or as a preservative, facilitating the presentation of antigens to immune cells (mast cells and basophils) during diagnostic testing.
The dose-response relationship of bromine is linear but has a very narrow therapeutic window. The onset of action for sedation is slow (days), as it takes time for the bromide ions to displace chloride in the CNS. Tolerance can develop over several months of use, but it is more often the case that 'pseudo-tolerance' occurs as the drug simply continues to accumulate to toxic levels.
| Parameter | Value |
|---|---|
| Bioavailability | >95% (Oral) |
| Protein Binding | <5% |
| Half-life | 9 - 14 Days |
| Tmax | 1 - 4 Hours |
| Metabolism | None (Elemental) |
| Excretion | Renal (95%+), Sweat/Feces (<5%) |
Bromine is classified as a Non-Standardized Food Allergenic Extract [EPC]. It also falls under the categories of CNS depressants (historically) and osmotic agents. It is chemically related to other halogens like Chlorine, Iodine, and Fluorine, but it is the only halogen that serves as a primary CNS sedative in its simple ionic form.
Common questions about Bromine
In modern medicine, Bromine is primarily used as a component in non-standardized food and plant allergenic extracts for allergy testing. Historically, it was widely used as a sedative and an anticonvulsant to treat epilepsy and 'nervousness.' It also serves as a trace element in some nutritional contexts and is used in the sanitization of medical environments. Your doctor might also use bromine-containing compounds to diagnose specific chemical sensitivities. Always consult a specialist to understand why a bromine-related product is being used in your care.
The most common side effects include significant drowsiness, sedation, and a metallic taste in the mouth. Patients often report feeling sluggish or fatigued, especially when starting treatment. Gastrointestinal upset, such as nausea or increased salivation, is also frequently noted. If bromine levels build up, a characteristic acne-like rash known as bromoderma may appear on the face or limbs. Because these symptoms can mimic other conditions, it is vital to report them to your healthcare provider immediately.
No, you should strictly avoid alcohol while taking bromine-containing medications. Both bromine and alcohol are central nervous system depressants, and combining them can lead to dangerous levels of sedation and respiratory depression. This combination significantly increases the risk of accidents, falls, and severe lethargy. Furthermore, alcohol can affect your hydration status, which may interfere with how your kidneys excrete bromine. Always discuss your lifestyle habits with your doctor before starting this medication.
Bromine is generally not recommended during pregnancy unless the benefits clearly outweigh the risks, as it readily crosses the placenta. Exposure during pregnancy can lead to neonatal bromism, where the newborn exhibits low muscle tone, lethargy, and feeding difficulties. There are also concerns regarding the potential for developmental delays with chronic exposure. If you are pregnant or planning to become pregnant, you must discuss alternative treatments with your healthcare provider. Diagnostic allergy testing involving bromine is usually postponed until after delivery.
The onset of action for bromine is quite slow compared to modern medications. While it is absorbed quickly into the bloodstream, it can take several days or even weeks of consistent dosing for the bromide ions to reach therapeutic levels in the brain. This is because bromine must slowly displace chloride ions in the extracellular fluid. For diagnostic allergy tests, however, the reaction is much faster, typically appearing within 15 to 20 minutes of skin contact. Your doctor will monitor your progress based on the specific use case.
You should never stop taking systemic bromine-containing medications abruptly. Because bromine has a very long half-life, stopping suddenly can cause a rapid shift in the chloride-bromide balance in your brain, which may trigger rebound symptoms or seizures. A healthcare provider will typically provide a tapering schedule to gradually lower the dose over several weeks. This allows your kidneys to slowly replace the bromide with chloride safely. Always follow the specific discontinuation plan provided by your medical team.
If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular routine. Do not take two doses at once to make up for the one you missed, as this increases the risk of accumulation and toxicity. Because bromine stays in your system for a long time, a single missed dose is unlikely to cause an immediate loss of effect, but consistency is important for long-term management. Contact your pharmacist if you miss multiple doses.
Weight gain is not a direct or common side effect of bromine itself. However, the sedation and lethargy caused by the drug may lead to a more sedentary lifestyle, which can indirectly result in weight gain over time. Additionally, some patients experience fluid retention if their salt intake is not properly managed while taking bromine. If you notice rapid weight gain or swelling in your extremities, it may be a sign of an electrolyte imbalance or kidney issue, and you should consult your doctor immediately.
Bromine has several significant drug interactions, particularly with other sedatives, diuretics, and medications that affect kidney function. It is especially sensitive to the amount of salt (sodium chloride) in your diet and medications. Taking bromine with other CNS depressants like benzodiazepines or opioids can be dangerous. Because of these complexities, you must provide your healthcare provider with a complete list of all medications, over-the-counter drugs, and herbal supplements you are currently taking to avoid serious complications.
Bromine is an element, so it is not 'branded' in the traditional sense, but the salts (like potassium bromide) are available as generic compounds. Most bromine-containing medications, such as certain inhalers or anti-spasmodics, are available in both brand-name and generic versions. Diagnostic allergenic extracts are typically produced by specialized laboratories and may not follow the standard brand/generic naming conventions. Your healthcare provider or pharmacist can help you identify the most cost-effective and appropriate version for your needs.